| Symbol |
Name |
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AIRE
|
autoimmune regulator
|
|
APOE
|
apolipoprotein E
|
|
ARHGEF10
|
Rho guanine nucleotide exchange factor (GEF) 10
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
CADM1
|
cell adhesion molecule 1
|
|
CALB2
|
calbindin 2
|
|
CALD1
|
caldesmon 1
|
|
CCKAR
|
cholecystokinin A receptor
|
|
CCKBR
|
cholecystokinin B receptor
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CHN1
|
chimerin 1
|
|
CLU
|
clusterin
|
|
DHH
|
desert hedgehog
|
|
DMPK
|
dystrophia myotonica-protein kinase
|
|
ECE1
|
endothelin converting enzyme 1
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
FBN2
|
fibrillin 2
|
|
FMR1
|
fragile X mental retardation 1
|
|
GAP43
|
growth associated protein 43
|
|
GCG
|
glucagon
|
|
GDNF
|
glial cell derived neurotrophic factor
|
|
GFRA1
|
GDNF family receptor alpha 1
|
|
GFRA2
|
GDNF family receptor alpha 2
|
|
GPR182
|
G protein-coupled receptor 182
|
|
GRIN1
|
glutamate receptor, ionotropic, N-methyl D-aspartate 1
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IL1B
|
interleukin 1, beta
|
|
IL31RA
|
interleukin 31 receptor A
|
|
ITGA6
|
integrin, alpha 6
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
JAM3
|
junctional adhesion molecule 3
|
|
JUN
|
jun proto-oncogene
|
|
KCNMA1
|
potassium channel, calcium activated large conductance subfamily M alpha, member 1
|
|
MPP5
|
membrane protein, palmitoylated 5 (MAGUK p55 subfamily member 5)
|
|
MPZ
|
myelin protein zero
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
NGFR
|
nerve growth factor receptor
|
|
NIPA1
|
non imprinted in Prader-Willi/Angelman syndrome 1
|
|
NPY
|
neuropeptide Y
|
|
NRG1
|
neuregulin 1
|
|
OPA1
|
optic atrophy 1 (autosomal dominant)
|
|
PMP22
|
peripheral myelin protein 22
|
|
RARB
|
retinoic acid receptor, beta
|
|
RET
|
ret proto-oncogene
|
|
SBF2
|
SET binding factor 2
|
|
SCN10A
|
sodium channel, voltage gated, type X alpha subunit
|
|
SLC18A3
|
solute carrier family 18 (vesicular acetylcholine transporter), member 3
|
|
SLC2A3
|
solute carrier family 2 (facilitated glucose transporter), member 3
|
|
SLC5A7
|
solute carrier family 5 (sodium/choline cotransporter), member 7
|
|
SLC6A2
|
solute carrier family 6 (neurotransmitter transporter), member 2
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SPG7
|
spastic paraplegia 7 (pure and complicated autosomal recessive)
|
|
TAC1
|
tachykinin, precursor 1
|
|
TACR2
|
tachykinin receptor 2
|
|
TGFB2
|
transforming growth factor, beta 2
|
|
TMEM100
|
transmembrane protein 100
|
|
TRPA1
|
transient receptor potential cation channel, subfamily A, member 1
|
|
TRPM8
|
transient receptor potential cation channel, subfamily M, member 8
|
|
TRPV1
|
transient receptor potential cation channel, subfamily V, member 1
|
|
TRPV3
|
transient receptor potential cation channel, subfamily V, member 3
|
|
TRPV4
|
transient receptor potential cation channel, subfamily V, member 4
|
|
TTR
|
transthyretin
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VIP
|
vasoactive intestinal peptide
|
|
WNT3A
|
wingless-type MMTV integration site family, member 3A
|
|
WT1
|
Wilms tumor 1
|